Breast Cancer Drugs: Many Play, Few Will Win

Although nearly 250 companies are working in the breast cancer treatment space, growth in the market will be driven by the uptake of three new drugs over the next 10 years and will plateau by 2018, according to a new market analysis from Decision Resources.
MedPage Today